Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p10
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 10/51)
Character Range: 26991–30067

(extended release) containing metformin hydrochloride 1 g [Brand: METEX XR; Maximum Quantity: 120; Number of Repeats: 5]
insert:
Metformin  Tablet (extended release) containing metformin hydrochloride 1 g  Oral  Metformin Sandoz XR  SZ  MP MW NP  C16261  P16261  60   5     60
Metformin  Tablet (extended release) containing metformin hydrochloride 1 g  Oral  Metformin Sandoz XR  SZ  MP NP     C14238  P14238  120  5     60

[52] Schedule 1, Part 1, entries for Modafinil
omit:
Modafinil  Tablet 100 mg  Oral  Modafinil Mylan  AF  MP  C10935 C10968 C10970     120  5     60

[53] Schedule 1, Part 1, entry for Mycobacterium bovis (Bacillus Calmette and Guerin), Tice strain
     omit from the column headed "Form": Vial containing powder for intravesical administration approximately 5 x 10{SUP}8{/SUP} CFU
     substitute: Vial containing powder for intravesical administration approximately 500 million CFU
[54] Schedule 1, Part 1, entries for Nicotine in each of the forms: Transdermal patch 17.5 mg; and Transdermal patch 35 mg
omit from the column headed "Responsible Person": ON substitute: UI
[55] Schedule 1, Part 1, entry for Nicotine in the form Transdermal patch 52.5 mg
omit from the column headed "Responsible Person": ON substitute: UI
[56] Schedule 1, Part 1, entry for Ofatumumab in the form Solution for injection 20 mg in 0.4 mL pre-filled pen [Maximum Quantity: 1; Number of Repeats: 5]
(a) omit from the column headed "Authorised Prescriber": MP substitute: MP NP
(b) omit from the column headed "Circumstances": C10172 substitute: C16301
(c) omit from the column headed "Purposes": P10172 substitute: P16301
[57] Schedule 1, Part 1, entry for Ofatumumab in the form Solution for injection 20 mg in 0.4 mL pre-filled pen [Maximum Quantity: 3; Number of Repeats: 0]
(a) omit from the column headed "Authorised Prescriber": MP substitute: MP NP
(b) omit from the column headed "Circumstances": C10162 substitute: C16323
(c) omit from the column headed "Purposes": P10162 substitute: P16323
[58] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 10 mg (orally disintegrating)
omit:
Olanzapine  Tablet 10 mg (orally disintegrating)  Oral  Olanzapine ODT generichealth 10  GQ  MP NP  C4246 C5869     28  5     28

[59] Schedule 1, Part 1, after entry for Opicapone
insert:
Osilodrostat  Tablet 1 mg (as phosphate)  Oral  Isturisa  RJ  MP  C16317         P16317         60  5     60
Osilodrostat  Tablet 1 mg (as phosphate)  Oral  Isturisa  RJ  MP  C16306 C16349  P16306 P16349  60  6     60
Osilodrostat  Tablet 5 mg (as phosphate)  Oral  Isturisa  RJ  MP  C16317         P16317         60  5     60
Osilodrostat  Tablet 5 mg (as phosphate)  Oral  Isturisa  RJ  MP  C16306 C16349  P16306 P16349  60  6     60

[60] Schedule 1, Part 1, entries for Ozanimod
substitute:
Ozanimod  Capsule 920 micrograms                                                   Oral  Zeposia  BQ  MP     C13995 C14003 C14004 C14005  P13995 P14003 P14004 P14005  28  3     28
Ozanimod  Capsule 920 micrograms                                                   Oral  Zeposia  BQ